y
188 Crk II C0853 1398 CRK P NP_005197.3 y y n/d
187 Crk-L C0978 1399 CRKL P NP_005198.1 y y n/d
534 p38 MAP Kinase, Non-Activated M8432 1432 MAPK14 M NP_001306.1 y y y
536 p38 MAPK activated (diphosphorylated
y
188 Crk II C0853 1398 CRK P NP_005197.3 y y n/d
187 Crk-L C0978 1399 CRKL P NP_005198.1 y y n/d
534 p38 MAP Kinase, Non-Activated M8432 1432 MAPK14 M NP_001306.1 y y y
536 p38 MAPK activated (diphosphorylated
y
188 Crk II C0853 1398 CRK P NP_005197.3 y y n/d
187 Crk-L C0978 1399 CRKL P NP_005198.1 y y n/d
534 p38 MAP Kinase, Non-Activated M8432 1432 MAPK14 M NP_001306.1 y y y
536 p38 MAPK activated (diphosphorylated
tiplex-PCR showed a clear amplification
for each target: 180 bp for stx1, 255 bp
for stx2, 384 bp for eaeA, 534 bp for
hlyA, and 910 bp for IS1203v, in 11 STEC
strains (Figure 1). Amplification of the
target genes
d
531 p300/CBP P2859 M y y y
532 p34cdc2 C3085 M y y n/d
533 p35 (Cdk5 Regulator) P9489 P y n/d y
534 p38 MAP Kinase, Non-Activated M8432 M y y y
535 p38 MAPK M0800 P n/d y y
536 p38 MAPK
; Rivero, I. A.;
Acosta-Martínez, D. R.; Pina-Luis, G.; Alatorre-Meda, M. Materials 2020,
13, 534.
(145) Jeon, O.; Bouhadir, K. H.; Mansour, J. M.; Alsberg, E. Biomaterials 2009,
30, 2724–2734.
; Rivero, I. A.;
Acosta-Martínez, D. R.; Pina-Luis, G.; Alatorre-Meda, M. Materials 2020,
13, 534.
(145) Jeon, O.; Bouhadir, K. H.; Mansour, J. M.; Alsberg, E. Biomaterials 2009,
30, 2724–2734.